The Appropriateness of Testing Platelet Factor 4/Heparin Antibody in Patients Suspected of Heparin-Induced Thrombocytopenia

Cureus
doi 10.7759/cureus.3532
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Cureus, Inc.

Related search

A Platelet Factor 4-Dependent Platelet Activation Assay Facilitates Early Detection of Pathogenic Heparin-Induced Thrombocytopenia Antibodies

Chest
CardiologyCritical CareCardiovascular MedicineIntensive Care MedicinePulmonaryRespiratory Medicine
2017English

Comparative Analysis of the Suspected Heparin-Induced Thrombocytopenia Level in Korea

Basic and Clinical Pharmacology and Toxicology
MedicineToxicologyPharmacology
2017English

Heparin-Induced Thrombocytopenia

Medicina
Medicine
2008English

Heparin-Induced Thrombocytopenia (HIT)

2018English

Management of Heparin Induced Thrombocytopenia.

BMJ
1993English

Heparin Neutralization by Platelet-Rich Thrombi. Role of Platelet Factor 4

Circulation
Cardiovascular MedicinePhysiologyCardiology
1994English

Heparin-Induced Thrombocytopenia: A Prospective Study of 142 Patients

Journal of Vascular Surgery
SurgeryCardiovascular MedicineCardiology
1985English

Argatroban Anticoagulant Therapy in Patients With Heparin-Induced Thrombocytopenia

Circulation
Cardiovascular MedicinePhysiologyCardiology
2001English

The Unique Immunological Features of Heparin-Induced Thrombocytopenia

British Journal of Haematology
Hematology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy